CIK 0001295947 · Large accelerated filer
Prestige Consumer Healthcare Inc.
Sign in to watch- Ticker
- PBH
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Entity type
- operating
- EIN
- 201297589
- Phone
- (914) 524-6800
- Business address
- 660 WHITE PLAINS RD., TARRYTOWN, NY, 10591
- Former names
- Prestige Brands Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-26 | Fritz Mary Beth SVP Quality & Regulatory | Sale 10b5-1 | −5,132 | $70.43 | $361K | 15,934 |
| 2024-02-26 | Fritz Mary Beth SVP Quality & Regulatory | Option exercise 10b5-1 | +4,545 | $30.56 | $139K | 20,479 |
| 2024-02-26 | Fritz Mary Beth SVP Quality & Regulatory | Sale 10b5-1 | −4,545 | $70.44 | $320K | 15,934 |
| 2024-02-26 | Fritz Mary Beth SVP Quality & Regulatory | Option exercise · Employee Stock Options (right to buy) 10b5-1 | −5,132 | 309 | ||
| 2024-02-26 | Fritz Mary Beth SVP Quality & Regulatory | Option exercise · Employee Stock Options (right to buy) 10b5-1 | −4,545 | 526 | ||
| 2024-02-23 | Fritz Mary Beth SVP Quality & Regulatory | Option exercise 10b5-1 | +12 | $57.18 | $686 | 15,946 |
| 2024-02-23 | Fritz Mary Beth SVP Quality & Regulatory | Sale 10b5-1 | −12 | $70.00 | $840 | 15,934 |
| 2024-02-23 | Fritz Mary Beth SVP Quality & Regulatory | Option exercise 10b5-1 | +11 | $30.56 | $336 | 15,945 |
| 2024-02-23 | Fritz Mary Beth SVP Quality & Regulatory | Sale 10b5-1 | −11 | $70.00 | $770 | 15,934 |
| 2024-02-23 | Fritz Mary Beth SVP Quality & Regulatory | Option exercise · Employee Stock Options (right to buy) 10b5-1 | −12 | 5,441 | ||
| 2024-02-23 | Fritz Mary Beth SVP Quality & Regulatory | Option exercise · Employee Stock Options (right to buy) 10b5-1 | −11 | 5,071 | ||
| 2024-02-15 | Mekhail Adel EVP, Marketing & Sales | Option exercise | +4,000 | $30.19 | $121K | 22,681 |
| 2024-02-15 | Mekhail Adel EVP, Marketing & Sales | Sale | −4,000 | $69.21 | $277K | 18,681 |
| 2024-02-15 | Mekhail Adel EVP, Marketing & Sales | Option exercise | +11,549 | $39.98 | $462K | 30,230 |
| 2024-02-15 | Mekhail Adel EVP, Marketing & Sales | Sale | −11,549 | $69.08 | $798K | 18,681 |
| 2024-02-15 | Mekhail Adel EVP, Marketing & Sales | Option exercise · Employee Stock Options (rights to buy) | −4,000 | 0 | ||
| 2024-02-15 | Mekhail Adel EVP, Marketing & Sales | Option exercise · Employee Stock Options (rights to buy) | −11,549 | 0 | ||
| 2024-02-14 | Sacco Christine Chief Financial Officer | Sale | −5,231 | $68.08 | $356K | 24,738 |
| 2024-02-14 | Sacco Christine Chief Financial Officer | Option exercise | +24,788 | $29.46 | $730K | 46,526 |
| 2024-02-14 | Sacco Christine Chief Financial Officer | Sale | −24,788 | $68.41 | $1.7M | 21,738 |
Page 10 of 12 · 225 trades